Table 2.
Comparison of number of molecules per organ system classification between the first and latest SA STG/EMLs
| Section of SA STG/EML | Primary Health Care | Adult Hospital | Paediatric Hospital | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1996 | 2008 | Ratio | 1998 | 2012 | Ratio | 1998 | 2013 | Ratio | |
| Alimentary Tract and Metabolism | 25 | 37 | 1.5 | 52 | 49 | 0.9 | 50 | 44 | 0.9 |
| Blood and Blood-forming Products | 4 | 11 | 2.8 | 18 | 23 | 1.3 | 26 | 33 | 1.3 |
| Cardiovascular System | 12 | 22 | 1.8 | 34 | 41 | 1.2 | 33 | 26 | 0.8 |
| Dermatologicals | 21 | 17 | 0.8 | 21 | 17 | 0.8 | 7 | 23 | 3.3 |
| Genitourinary System and Sex Hormones | 18 | 17 | 0.9 | 30 | 28 | 0.9 | 5 | 8 | 1.6 |
| Systemic Hormonal Preparations, excluding Sex Hormones | 2 | 2 | 1.0 | 15 | 17 | 1.1 | 9 | 12 | 1.3 |
| General Anti-infectives for Systemic Use | 39 | 55 | 1.4 | 73 | 83 | 1.1 | 62 | 98 | 1.6 |
| Antineoplastic and Immunomodulating Agents | 0 | 0 | 0.0 | 29 | 8 | 0.3 | 30 | 5 | 0.2 |
| Musculoskeletal System | 4 | 4 | 1.0 | 11 | 12 | 1.1 | 8 | 3 | 0.4 |
| Central Nervous System | 21 | 30 | 1.4 | 58 | 53 | 0.9 | 41 | 41 | 1.0 |
| Antiparasitic Products | 10 | 10 | 1.0 | 9 | 7 | 0.8 | 10 | 9 | 0.9 |
| Respiratory System | 10 | 15 | 1.5 | 11 | 14 | 1.3 | 11 | 18 | 1.6 |
| Sensory Organs | 8 | 9 | 1.1 | 14 | 28 | 2.0 | 10 | 12 | 1.2 |
| Various | 6 | 2 | 0.3 | 22 | 15 | 0.7 | 14 | 10 | 0.7 |